Variant report
Variant | esv3404395 |
---|---|
Chromosome Location | chr7:11698727-11703625 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:11693718..11695919-chr7:11698554..11700578,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188229536 | chr7:11698760-11698761 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550097172 | chr7:11698768-11698769 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573966262 | chr7:11698800-11698801 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374410596 | chr7:11698801-11698802 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569959975 | chr7:11698803-11698804 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs536720338 | chr7:11698812-11698813 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555355388 | chr7:11698880-11698881 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138338711 | chr7:11698900-11698901 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143822090 | chr7:11698912-11698913 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536438560 | chr7:11698923-11698924 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548839825 | chr7:11698924-11698925 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543643358 | chr7:11698954-11698955 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146217791 | chr7:11698961-11698962 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573949361 | chr7:11698962-11698963 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542631413 | chr7:11699022-11699023 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559285804 | chr7:11699025-11699026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs528450315 | chr7:11699049-11699050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs725588 | chr7:11699149-11699150 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs573155936 | chr7:11699151-11699152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565233128 | chr7:11699182-11699183 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533195891 | chr7:11699333-11699334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2078585 | chr7:11699336-11699337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs193175479 | chr7:11699366-11699367 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373931666 | chr7:11699367-11699368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs79616805 | chr7:11699373-11699374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563705764 | chr7:11699382-11699383 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563581259 | chr7:11699427-11699428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs57298572 | chr7:11699463-11699464 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs543144051 | chr7:11699481-11699482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549015290 | chr7:11699557-11699558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565714306 | chr7:11699578-11699579 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534319446 | chr7:11699583-11699584 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs138658202 | chr7:11699607-11699608 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs149315287 | chr7:11699620-11699621 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs563236920 | chr7:11699630-11699631 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs28497544 | chr7:11699638-11699639 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs557101580 | chr7:11699644-11699645 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs144553682 | chr7:11699711-11699712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs78463346 | chr7:11699736-11699737 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs57380018 | chr7:11699763-11699764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs148442878 | chr7:11699770-11699771 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541378805 | chr7:11699773-11699774 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs75765620 | chr7:11699789-11699790 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs528886819 | chr7:11699796-11699797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183979685 | chr7:11699816-11699817 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs116072282 | chr7:11699856-11699857 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142503674 | chr7:11699874-11699875 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs529085237 | chr7:11699877-11699878 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188712936 | chr7:11699893-11699894 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs191388119 | chr7:11699956-11699957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Autism | 22495309 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Melanoma | 20877625 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:11689400-11704200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr7:11695400-11699000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
3 | chr7:11698000-11699000 | Active TSS | A549 | lung |
4 | chr7:11698200-11699000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr7:11698400-11704200 | Weak transcription | Fetal Brain Male | brain |
6 | chr7:11698600-11699000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr7:11699000-11699200 | Weak transcription | A549 | lung |
8 | chr7:11699000-11699600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
9 | chr7:11699200-11700000 | Enhancers | A549 | lung |
10 | chr7:11700000-11700400 | Weak transcription | A549 | lung |
11 | chr7:11700400-11702200 | Enhancers | A549 | lung |
12 | chr7:11702200-11704200 | Weak transcription | A549 | lung |